Cambridge Conference on Breast Cancer Imaging 2026

Supporters

Thank you to our below supporters who have sponsored and will be exhibiting at the Cambridge Conference on Breast Cancer Imaging 2026. You will have the opportunity, during the conference, to pop in and have a face to face chat with them.

Please click on their logos to visit their websites for further information.

Silver Supporters

As a science company with over 100 years of expertise in diagnostic imaging, Bayer are committed to developing innovative products, software, and services to help Radiology departments operate at a high level of care.

Bayer offers all this with expert service to ensure Radiology ecosystems are maintained to a high standard including remote support for rapid assistance.

Bayer’s Radiology business is well placed to be the partner of choice in helping radiology services address the many challenges faced today.

BD is a global medical technology company that is advancing the world of health by improving medical discovery, diagnostics and the delivery of care. BD leads in patient and health care worker safety and the technologies that enable medical research and clinical laboratories. The company provides innovative solutions that help advance medical research and genomics, enhance the diagnosis of infectious disease and cancer, improve medication management, promote infection prevention, equip surgical and interventional procedures and support the management of diabetes.

BD Interventional - Peripheral Intervention focuses on being at the forefront of developing innovative medical devices that solve the challenges of healthcare professionals and improving the quality of patients’ lives. We are committed to pursuing technological innovations that offer superior clinical benefits while helping to reduce overall health care costs.

FUJIFILM Healthcare UK is a leading provider of innovative medical imaging systems and healthcare solutions. Our portfolio covers Digital X-ray, Mammography, Ultrasound, CT, MRI, Enterprise Imaging solutions (including PACS, VNA, and 3D surgical planning tools), Cardiology, AI, Digital Pathology and near patient IVD testing analysers for dry chemistry.

With a history of manufacturing X-ray film since the 1930s, for decades we have been using our heritage in photography and film to bring exciting new solutions to the healthcare market. By leveraging advanced technology from across a broad business, we have developed new ways of meeting the needs of modern healthcare by providing value through innovation.

We continue to prioritise innovation and look towards the healthcare needs of tomorrow, while we remain proudly by your side.

MIS Healthcare is a UK based exclusive distributor for world leading medical manufacturers, providing state of the art products ranging from high end medical imaging diagnostic equipment, PACS/RIS, medical consumables and diagnostic instruments.

At Siemens Healthineers, we pioneer breakthroughs in healthcare. For everyone. Everywhere. Sustainably. As a leader in medical technology, we want to advance a world in which breakthroughs in healthcare create new possibilities with a minimal impact on our planet. By consistently bringing innovations to the market, we enable healthcare professionals to innovate personalised care, achieve operational excellence and transform the system of care.

Our portfolio, spanning in vitro and in vivo diagnostics to image-guided therapy and cancer care, is crucial for clinical decision-making and treatment pathways. With the unique combination of our strengths in patient twinning, precision therapy, as well as digital, data and artificial intelligence (AI), we are well positioned to take on the greatest challenges in healthcare. We will continue to build on these strengths to help overcome the world’s most threatening diseases, enable efficient operations, and expand access to care.

Bronze Supporters

DetectedX is an Australian medical imaging education and diagnostic improvement company that helps radiologists and clinicians improve the accuracy of detecting diseases such as breast and lung cancer through interactive, cloud-based training platforms. Originally developed from the University of Sydney’s BREAST screening research program, the company provides self-assessment modules using real patient imaging cases, instant performance feedback, benchmarking, and CME/CPD-accredited learning tools designed to reduce diagnostic errors and improve early disease detection rates.

DetectedX combines radiology expertise, AI-supported educational technology, and full-resolution image analysis to support healthcare professionals globally, with users across more than 150 countries and partnerships with major healthcare imaging organisations.

InHealth Group is one of the UK’s largest independent providers of diagnostic and healthcare services, working closely with the NHS and private healthcare sector to deliver imaging, screening, and outpatient services across the country. Founded more than 30 years ago, the company operates a nationwide network of community diagnostic centres, mobile imaging units, hospitals, and clinics, providing services such as MRI, CT, PET-CT, endoscopy, mammography, audiology, cardiac diagnostics, and diabetic eye screening. InHealth’s core focus is reducing NHS waiting times, improving access to early diagnosis, and delivering care closer to patients’ homes through both fixed and mobile facilities. The organisation reports serving more than 5 million patients annually across 900+ locations with over 3,500 staff, and has expanded heavily into Community Diagnostic Centres (CDCs), a key part of the NHS diagnostic recovery strategy. It also operates related healthcare brands including Vista Health and InHealth Ventures.

The Jarvis National Breast Education and Training Centre, operated in partnership with InHealth Group, is one of England’s designated specialist breast imaging training centres supporting the NHS Breast Screening Programme. Based at the Jarvis Breast Centre in Guildford, the centre provides postgraduate education, clinical training, apprenticeships, and advanced practice modules for mammographers, radiographers, breast clinicians, and other healthcare professionals working in breast screening and diagnostics. Working alongside institutions including St George's University of London, Royal Free London NHS Foundation Trust, and the National Breast Imaging Academy, the centre helps address national workforce shortages in breast imaging through accredited Level 4 and Level 5 mammography apprenticeships, MSc-level advanced breast practice programmes, and specialist image interpretation training. It is recognised nationally for combining hands-on clinical education with NHS service delivery, contributing to improved breast cancer screening quality, workforce development, and earlier cancer detection across the UK.

Innoventa Medica’s mission is to provide, innovative, safe and effective medical technology solutions serving patients undergoing surgical procedures or therapy areas, where an unmet medical need exists.

During the Cambridge Conference on Breast Cancer Imaging 2026, we bring you Seroma Set, a sterile, single-use, closed system for drainage of post-operative seroma (with and without ultrasound-guidance). Seroma Set is a simpler, more ergonomic way to remove seroma. Seroma Set replaces repetitive syringe pumping with a single-handed, continuous aspiration method. Pop along to our stand and collect your free Seroma Sets to evaluate in your own practice.

MedEikon helps deliver faster, smarter, and more accessible healthcare. By powering mobile scanning units across the UK, we support shorter waiting times, cost-effective NHS solutions, earlier diagnosis, and greater convenience for patients—bringing high-quality diagnostic services directly into local communities where they’re needed most.

Medilife will be showcasing new medical device innovations that improve diagnosis and support better outcomes for women with or at risk of breast cancer. Visit us and chat to Paul Rowe and Ian Galloway to find out about our novel surgical devices, new breast imaging modality, and software to speed reporting.

Founded in 1987, Merit Medical Systems, Inc. is a leading manufacturer and marketer of proprietary disposable medical devices used in interventional, diagnostic and therapeutic procedures, particularly in cardiology, radiology, oncology, critical care and endoscopy.

Designed to improve patient outcomes, the SCOUT® Radar Localization system represents Merit Oncology's strong commitment to reducing the burden of breast cancer on patients and their loved ones.

The SCOUT® Radar Localization system represents the latest advancement in breast-conserving surgery, using the only non-magnetic and non-radioactive localization technology available.

As the global leader in wire-free localization, we are proud to have made a difference in the lives of over 850,000 patients worldwide.

CHOOSE WISELY. CHOOSE SCOUT®

The National Breast Imaging Academy programme is a collaborative, national, multidisciplinary initiative which encompasses a range of solutions to address the severe workforce issues faced in the delivery of breast imaging services across the country. Proposals include the establishment of a national centre of excellence for training, the development of high-quality training programmes for all staff and an innovative, online, technology-enhanced learning hub.

Charity Supporters

Future Dreams Breast Cancer Charity believes nobody should face breast cancer alone or without hope. The charity offers a wide range of in-person and online services providing practical, emotional and psychological support for those diagnosed with breast cancer, funds vital secondary breast cancer research, and promotes breast health education. In October 2021 the charity opened Future Dreams House, one of the only dedicated breast cancer support centre in England and Wales. No referrals needed.

Supporters

Follow us online